{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:24:47Z","timestamp":1791894287976,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1053\/j.ajkd.2008.07.038","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T04:23:08Z","timestamp":1225513388000},"page":"259-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Interventions for Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: A Systematic Review of Randomized Controlled Trials"],"prefix":"10.1053","volume":"53","author":[{"given":"Mini","family":"Michael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Ridley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M.","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2008.07.038_bib1","first-page":"3","article-title":"Thrombotic microangiopathy: A proposal for a new terminology for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura","volume":"8","author":"Kaplan","year":"1995","journal-title":"J Nephrol"},{"key":"10.1053\/j.ajkd.2008.07.038_bib2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.5858\/2003-127-834-TTPAHU","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities","volume":"127","author":"Hosler","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.ajkd.2008.07.038_bib3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.07.038_bib4","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.07.038_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2002-02-0344","article-title":"von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: A severely deficient activity is specific for thrombotic thrombocytopenic purpura","volume":"100","author":"Bianchi","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2008.07.038_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830500203","article-title":"Increasing mortality from thrombotic thrombocytopenic purpura in the United States\u2014Analysis of national mortality data, 1968-1991","volume":"50","author":"Torok","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1053\/j.ajkd.2008.07.038_bib7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: All patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.ajkd.2008.07.038_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura: Report of 16 cases and review of literature","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.ajkd.2008.07.038_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2008.07.038_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2003.04049.x","article-title":"Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology: Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias","volume":"120","author":"Allford","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.ajkd.2008.07.038_bib11","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM197712222972507","article-title":"Treatment of thrombotic thrombocytopenic purpura with plasma","volume":"297","author":"Byrnes","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.07.038_bib12","first-page":"219","article-title":"Exchange transfusion in the treatment of thrombotic thrombocytopenic purpura","volume":"13","author":"Bukowski","year":"1976","journal-title":"Semin Hematol"},{"key":"10.1053\/j.ajkd.2008.07.038_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1996.d01-1800.x","article-title":"Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura","volume":"94","author":"Rock","year":"1996","journal-title":"Br J Haematol"},{"issue":"suppl 95","key":"10.1053\/j.ajkd.2008.07.038_bib14","first-page":"63S","article-title":"Solvent detergent-treated plasma versus fresh frozen plasma in patients with TTP","volume":"36","author":"Sacher","year":"1996","journal-title":"Transfusion"},{"key":"10.1053\/j.ajkd.2008.07.038_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.07.038_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ki.1995.261","article-title":"The hemolytic uremic syndrome","volume":"47","author":"Remuzzi","year":"1995","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.07.038_bib17","series-title":"Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura","first-page":"213","article-title":"Hemolytic uremic syndrome in families","author":"Kaplan","year":"1992"},{"key":"10.1053\/j.ajkd.2008.07.038_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2001-15247","article-title":"Hemolytic uremic syndrome and complement factor H deficiency: Clinical aspects","volume":"27","author":"Taylor","year":"2001","journal-title":"Semin Thromb Haemost"},{"key":"10.1053\/j.ajkd.2008.07.038_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/adc.85.2.125","article-title":"Nationwide study of haemolytic uraemic syndrome: Clinical microbiological, and epidemiological features","volume":"85","author":"Elliott","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1053\/j.ajkd.2008.07.038_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3476(05)80730-9","article-title":"Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988","volume":"119","author":"Rowe","year":"1991","journal-title":"J Pediatr"},{"key":"10.1053\/j.ajkd.2008.07.038_bib21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/adc.65.7.716","article-title":"Haemolytic uraemic syndromes in the British Isles 1985-8: Association with verocytotoxin producing Escherichia coli","volume":"65","author":"Milford","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1053\/j.ajkd.2008.07.038_bib22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM199010253231703","article-title":"The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota","volume":"323","author":"Martin","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.07.038_bib23","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2008.07.038_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S0950268899003623","article-title":"Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France","volume":"124","author":"Decludt","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1053\/j.ajkd.2008.07.038_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/adc.76.6.518","article-title":"Heterogeneity of atypical haemolytic uraemic syndromes","volume":"76","author":"Neuhaus","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1053\/j.ajkd.2008.07.038_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2008.07.038_bib27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis?","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2008.07.038_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2008.07.038_bib29","first-page":"1410","article-title":"Empirical evidence of bias","volume":"301","author":"Schultz","year":"1995","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2008.07.038_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2008.07.038_bib31","first-page":"429","article-title":"Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP)","volume":"82","author":"Bobbio-Pallavicini","year":"1997","journal-title":"Haematologica"},{"key":"10.1053\/j.ajkd.2008.07.038_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0955-3886(92)90123-X","article-title":"Thrombotic thrombocytopenic purpura: Clinical results of a French controlled trial","volume":"13","author":"Henon","year":"1992","journal-title":"Transfus Sci"},{"key":"10.1053\/j.ajkd.2008.07.038_bib33","first-page":"15","article-title":"Treatment of haemolytic uraemic syndrome in children with urokinase","volume":"41","author":"Loirat","year":"1984","journal-title":"Arch Fr Pediatr"},{"key":"10.1053\/j.ajkd.2008.07.038_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00858677","article-title":"Treatment of the childhood haemolytic uraemic syndrome with plasma","volume":"2","author":"Loriat","year":"1988","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2008.07.038_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s004670050413","article-title":"Steroids in hemolytic uremic syndrome","volume":"12","author":"Perez","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2008.07.038_bib36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-3476(88)80071-4","article-title":"Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial","volume":"112","author":"Rizzoni","year":"1988","journal-title":"J Paediatr"},{"key":"10.1053\/j.ajkd.2008.07.038_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.07.038_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.2005.05418.x","article-title":"Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura?","volume":"129","author":"Rock","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.ajkd.2008.07.038_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1526-0968.2000.004005327.x","article-title":"Design of the prospective randomised study for the treatment of patients with thrombotic microangiopathy","volume":"4","author":"Rothele","year":"2000","journal-title":"Ther Apher"},{"key":"10.1053\/j.ajkd.2008.07.038_bib40","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","article-title":"Effect of an oral Shiga toxin-binding agent on diarrhoea-associated haemolytic uraemic syndrome in children; A randomised controlled trial","volume":"290","author":"Trachtman","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2008.07.038_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(88)80031-3","article-title":"Heparin plus dipyridamole in childhood hemolytic-uraemic syndrome: A prospective randomized study","volume":"113","author":"Van Damme-Lombaerts","year":"1988","journal-title":"J Pediatr"},{"key":"10.1053\/j.ajkd.2008.07.038_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3476(73)80490-1","article-title":"Heparin therapy in the haemolytic uraemic syndrome","volume":"83","author":"Vitacco","year":"1973","journal-title":"J Pediatr"},{"key":"10.1053\/j.ajkd.2008.07.038_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jca.1003","article-title":"Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic prupura (TTP)","volume":"16","author":"Zeigler","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1053\/j.ajkd.2008.07.038_bib44","first-page":"446A","article-title":"Efficacy of therapeutic plasma exchange in haemolytic uraemic syndrome in childhood (abstracts, European Dialysis and Transplant Association-European Renal Association XXVIth Annual Congress, G\u00f6teborg, Sweden, 11-15 June 1989)","volume":"4","author":"Muller-Wiefel","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.07.038_bib45","unstructured":"Thomson PD, Milnor LS: A randomly selected trial of vitamin E in the haemolytic uraemic syndrome (HUS). Proceedings of Xth International Congress of Nephrology 98 (Abstracts), London, July 26-31, 1987"},{"key":"10.1053\/j.ajkd.2008.07.038_bib46","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJMcp053024","article-title":"Thrombotic thrombocytopenic purpura","volume":"354","author":"George","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.07.038_bib47","first-page":"977","article-title":"Vincristine for TTP","volume":"340","author":"Durand","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2008.07.038_bib48","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/0140-6736(90)93214-A","article-title":"Cyclophosphamide for chronic relapsing TTP","volume":"336","author":"Udvardy","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2008.07.038_bib49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-125-4-199608150-00006","article-title":"Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura","volume":"125","author":"Crowther","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2008.07.038_bib50","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood-2005-03-0848","article-title":"Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient TTP: A study of 11 cases","volume":"105","author":"Fakhouri","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2008.07.038_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jca.20091","article-title":"Rituximab therapy for TTP: A proposed study of the Transfusion Medicine\/Hemostatsis Clinical Trials Network with a systematic review of rituximab therapy for immune mediated disorders","volume":"21","author":"George","year":"2006","journal-title":"J Clin Apher"},{"key":"10.1053\/j.ajkd.2008.07.038_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0749-0704(03)00010-1","article-title":"Renal failure and renal replacement therapy","volume":"19","author":"Maxvold","year":"2003","journal-title":"Crit Care Clin"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608012407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608012407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:51:38Z","timestamp":1759456298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608012407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0272638608012407"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.07.038","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.721895840.793501516","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interventions for Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: A Systematic Review of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}